NCT06694948View on ClinicalTrials.gov

A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

January 3, 2025

Study Completion Date

January 17, 2025

Conditions
Pharmacokinetics
Interventions
DRUG

pimicotinib capsules

pimicotinib capsules

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Abbisko Therapeutics Co, Ltd

INDUSTRY